NEW YORK (GenomeWeb News) – Linkage Biosciences has raised $2 million in a Series A round of financing, the molecular diagnostics firm said today.
Linkage Bio said the funding round was led by Greenhouse Capital Partners and James R. Fisher, managing member of Fisher Capital Corp. II, a firm that works exclusively with Kohlberg Kravis Roberts.
The firm expects to use the proceeds to support continued development and marketing of Linakge Bio's molecular diagnostic products. It is focused on human leukocyte antigen typing for organ transplantation but also is developing products for other transplant diagnostics and complex genetic disorders.
San Francisco-based Linkage Bio also said that Rebecca Bishop, who is an executive at Affymetrix, and Pascal Villiger of CalSTRS' private equity division, have joined its board of directors.